Cengild Medical Bhd (CENGILD.KL) Stock Price

Cengild Medical Bhd Price

CLOSED
0.16
​
Market closed

Revenue has compounded at 25.8% per year over the past 8 years to 73.21 M MYR. Earnings per share have grown at 33.6% per year over the last 7 years. Cengild Medical Bhd's net margin stands at 15.6%, up from 14.6% several years earlier. Cengild Medical Bhd currently offers a dividend yield of about 4.38%. The payout ratio is around 58% of earnings. The dividend has grown at 17.3% per year over the past 4 years.

Cengild Medical Bhd stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cengild Medical Bhd business model & stock analysis

Cengild Medical Bhd.engages in the provision of healthcare services specializing in the diagnosis and treatment of gastrointestinal and liver diseases, and obesity. The company is headquartered in Kuala Lumpur, Kuala Lumpur. The company went IPO on 2022-04-18. The Company, through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. The firm has around 36,588 sq. ft. medical center, which provides diagnostic and therapeutic facilities with 28 licensed beds, two fully equipped operating theatres, three endoscopy suites, and imaging facilities such as fibro scan, ultrasonography, computerized tomography (CT) scan, fluoroscopy, angiography equipment for endoscopic retrograde cholangiopancreatography (ERCP)s and other procedures. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy, and histopathology services. Its subsidiaries include Cengild Sdn. Bhd., and Galen Primer Sdn. Bhd.

Frequently asked questions about Cengild Medical Bhd

Converted at the current exchange rate, the Cengild Medical Bhd share trades at 0.03 EUR (0.16 MYR).

The revenue of Cengild Medical Bhd is 73.21 M MYR. This figure is based on current financial data and reflects the company's business performance.

The profit of Cengild Medical Bhd is 11.44 M MYR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Cengild Medical Bhd is currently 11.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cengild Medical Bhd stock.

The price-to-sales ratio (P/S) of Cengild Medical Bhd is currently 1.82. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cengild Medical Bhd stock.

The Eulerpool Quality Score for Cengild Medical Bhd is 1/10.

The ISIN of Cengild Medical Bhd is MYQ0243OO004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cengild Medical Bhd is CENGILD.KL. The ticker symbol is used to trade Cengild Medical Bhd shares on the stock exchange.

Fair ValueTerminal
0.13 MYR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Malaysia
Currency
MYR
Initial public offering
Apr 18, 2022
ISIN
MYQ0243OO004
Cusip
Y163F4104
Market capitalization
133.27 M MYRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
14.83
P/B Ratio
1.11
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.62 %
Dividend
Dividend yield
4.38 %
Payout Ratio
58.37 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
4 years
Dividend not reduced since
4 years
Dividend increased since
1 year
Dividend withholding tax
0.00 %
Last updated Oct 20, 2026, 2:34 PM

Cengild Medical Bhd Peer Group

Cengild Medical Bhd FIGI

CENGILD:MK · BBG016FQTGV0